| Key Financial Ratios of Marksans Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
4.15 |
2.95 |
2.48 |
2.54 |
2.40 |
|
| Diluted EPS (Rs.) |
4.15 |
2.95 |
2.48 |
2.54 |
2.40 |
|
| Cash EPS (Rs.) |
4.80 |
3.59 |
2.64 |
2.97 |
2.77 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
30.53 |
26.98 |
24.52 |
19.17 |
14.65 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
30.53 |
26.98 |
24.52 |
19.17 |
14.65 |
|
| Dividend / Share(Rs.) |
0.80 |
0.60 |
0.50 |
0.25 |
0.25 |
|
| Revenue from Operations/Share (Rs.) |
25.92 |
18.83 |
14.46 |
16.08 |
14.65 |
|
| PBDIT/Share (Rs.) |
6.04 |
4.46 |
3.36 |
3.81 |
3.54 |
|
| PBIT/Share (Rs.) |
5.39 |
3.81 |
2.99 |
3.38 |
3.17 |
|
| PBT/Share (Rs.) |
5.37 |
3.79 |
2.91 |
3.29 |
3.04 |
|
| Net Profit/Share (Rs.) |
4.15 |
2.95 |
2.27 |
2.54 |
2.40 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
23.32 |
23.67 |
23.25 |
23.69 |
24.16 |
|
| PBIT Margin (%) |
20.81 |
20.26 |
20.70 |
21.00 |
21.62 |
|
| PBT Margin (%) |
20.71 |
20.14 |
20.15 |
20.43 |
20.73 |
|
| Net Profit Margin (%) |
16.03 |
15.67 |
15.69 |
15.79 |
16.40 |
|
| Return on Networth / Equity (%) |
13.60 |
10.93 |
9.25 |
13.25 |
16.40 |
|
| Return on Capital Employed (%) |
17.33 |
13.90 |
12.02 |
17.30 |
20.79 |
|
| Return on Assets (%) |
10.72 |
8.82 |
7.64 |
10.76 |
13.69 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.72 |
0.60 |
0.57 |
0.78 |
83.43 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.13 |
3.48 |
4.22 |
3.54 |
3.68 |
|
| Quick Ratio (X) |
2.54 |
2.78 |
3.62 |
2.92 |
2.69 |
|
| Inventory Turnover Ratio (X) |
5.93 |
2.53 |
2.89 |
3.32 |
6.40 |
|
| Dividend Payout Ratio (NP) (%) |
14.44 |
16.93 |
9.88 |
9.84 |
4.16 |
|
| Dividend Payout Ratio (CP) (%) |
12.48 |
13.91 |
8.50 |
8.41 |
3.60 |
|
| Earnings Retention Ratio (%) |
85.56 |
83.07 |
90.12 |
90.16 |
95.84 |
|
| Cash Earnings Retention Ratio (%) |
87.52 |
86.09 |
91.50 |
91.59 |
96.40 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
9,807.32 |
6,555.41 |
2,754.06 |
1,645.36 |
1,938.81 |
|
| EV/Net Operating Revenue (X) |
8.35 |
7.68 |
4.20 |
2.50 |
3.23 |
|
| EV/EBITDA (X) |
35.81 |
32.45 |
18.07 |
10.55 |
13.38 |
|
| MarketCap/Net Operating Revenue (X) |
8.58 |
8.05 |
4.88 |
2.83 |
3.41 |
|
| Retention Ratios (%) |
85.55 |
83.06 |
90.11 |
90.15 |
95.83 |
|
| Price/BV (X) |
7.28 |
5.62 |
2.87 |
2.38 |
3.41 |
|
| Price/Net Operating Revenue |
8.58 |
8.05 |
4.88 |
2.83 |
3.41 |
|
| Earnings Yield |
0.02 |
0.02 |
0.03 |
0.06 |
0.05 |
|
Source : Dion Global Solutions Limited
